Endoscopic pancreatic stenting following pancreatic papilla dilation without pancreatic sphincterotomy

A. Ertan

Research output: Contribution to journalArticle

Abstract

This study prospectively evaluated the efficacy, safety, and outcome of endoscopic pancreatic stenting (EPS) following pancreatic papilla dilation by dilating catheters instead of pancreatic sphincterotomy in selected patients with pancreatitis. The approach was in nine women and six men, aged 19 to 55, with pancreatic pain. A guide wire was pushed into the pancreatic duct after its deep cannulating. The, pancreatic papilla dilation was performed using 4.6F to 10F dilating catheters, and a pancreatic stent was inserted. With a mean 18 months follow-up, pancreatic pain improved in 14 to 15 patients and complete pseudocyst resolution occurred in seven of eight patients. This experience indicates that EPS after pancreatic papilla dilation, without sphincterotomy, is a safe and effective procedure for pancreatic pain relief and pseudocyst resolution in selected pancreatitis patients.

Original languageEnglish (US)
Pages (from-to)402-405
Number of pages4
JournalTurkish Journal of Gastroenterology
Volume8
Issue number4
StatePublished - Dec 1 1997

Keywords

  • Chronic pancreatitis
  • Endoscopic
  • Stenting
  • Therapy

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Endoscopic pancreatic stenting following pancreatic papilla dilation without pancreatic sphincterotomy'. Together they form a unique fingerprint.

Cite this